SCHEMBL6676522

SCHEMBL6676522

Nc1ccn(C2OC(CO)C(O)C2O)c(=O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.62
MTOR P42345 2/20 0.62
THRB P10828 1/20 0.62
MDM2 Q00987 1/20 0.62
NCOA1 Q15788 1/20 0.62
NCOA3 Q9Y6Q9 1/20 0.62
SLC28A1 O00337 1/20 0.58
SLC28A2 O43868 1/20 0.58
SLC29A1 Q99808 1/20 0.58
SLC28A3 Q9HAS3 1/20 0.58
MAPT P10636 2/20 0.52
CDA P32320 1/20 0.52
ALDH1A1 P00352 3/20 0.52
TP53 P04637 2/20 0.52
HTT P42858 2/20 0.52
BLM P54132 2/20 0.52
GMNN O75496 1/20 0.52
NFKB1 P19838 1/20 0.52
DNMT1 P26358 1/20 0.52
THPO P40225 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21184966 1.00 LMNA (0.62) LMNAMTORTHRBMDM2NCOA1
SCHEMBL2115033 1.00 LMNA (0.62) LMNAMTORTHRBMDM2NCOA1
SCHEMBL9293560 0.84 SLC28A1 (0.59) LMNAMTORTHRBMDM2NCOA1
SCHEMBL4293684 0.84 SLC28A1 (0.59) LMNAMTORTHRBMDM2NCOA1
SCHEMBL13657982 0.84 SLC28A1 (0.59) LMNAMTORTHRBMDM2NCOA1
SCHEMBL352974 0.84 SLC28A1 (0.59) LMNAMTORTHRBMDM2NCOA1
SCHEMBL12594002 0.84 SLC28A1 (0.59) LMNAMTORTHRBMDM2NCOA1
Cytidine SCHEMBL29260505 0.78 LMNA (0.97) LMNAMTORTHRBMDM2NCOA1
SCHEMBL7028245 0.78 MAPT (0.63) LMNAMTORTHRBMDM2NCOA1
SCHEMBL7028251 0.78 MAPT (0.63) LMNAMTORTHRBMDM2NCOA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004037159-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR MODULATING FAT METABOLISM OBETHERAPY BIOTECHNOLOGY (FR) 2004-05-06 WO disclosed